About

About Virscio, Inc. Virscio is uniquely positioned to support nonhuman primate (NHP) ophthalmic development programs through expertly designed in vivo studies and high-quality, integrated histopathology, image analysis, and molecular assays. Our team includes board-certified ophthalmologists, pathologists and PhD scientists with deep expertise in ocular biology, disease modeling, and translational research, enabling design and execution of the optimal studies for critical development needs. Integration of in vivo ophthalmic assessments and histopathology accelerates and enhances interpretations to achieve detailed tissue pharmacodynamic and safety assessments. Specializing in ocular tissues, we offer standalone histopathology and image analysis to support analysis of primate and non-primate specimens from other testing facilities. Virscio partners closely with sponsors across early feasibility and IND-enabling programs to deliver robust data in support of successful advance to clinic.